Author

Sevil Raji

Institution: Tarbiat Modares University

Observed institution: Tarbiat Modares University

OpenAlex ID: A5117734586

Integrating CRISPR/Cas technology with clinical trials: Principles, progress and challenges

2025 · Piao Yang, Mohadeseh Khoshandam, et al. · Asian Journal of Pharmaceutical Sciences · 6

CRISPR/Cas9-Mediated Targeting of the Integrin Beta-2 Gene as a Gene-Editing Strategy for Leukocyte Adhesion Deficiency Type I.

2026 · Sevil Raji, Hossein Soltaninejad, et al. · PubMed

Works count: 2

Citation count: 6

H-index: 1

I10-index: